» Articles » PMID: 34675680

Circular RNA Circ-0003006 Promotes Hepatocellular Carcinoma Proliferation and Metastasis Through Sponging MiR-542-3p and Regulating HIF-1A

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2021 Oct 22
PMID 34675680
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Hepatocellular carcinoma (HCC) is one most common cancer types among gastrointestinal cancer over the world, while its underlying mechanisms remain unclear. CircRNA has been revealed to participate in multiple biological functions and contribute to various diseases' progression.

Methods: Bioinformatic analysis of the differently expressed circRNAs in the HCC tissues, then verified by real-time quantitative PCR (RT-qPCR) assay. We found that circ-0003006 was upregulated in the HCC tissues, the cell fractionation assay and RNA fluorescence in situ hybridization (FISH) were performed to confirm the cell location of circ-0003006. shRNA silence assay was used to knock down the expression of circ-0003006 in the HCC cells.

Results: Cell account kit 8 (CCK-8) and transwell assay were revealed that circ-0003006 knockdown inhibited the proliferation and metastasis in HCC cells. The target miR‑542‑3p and target gene HIF-1A were predicted by bioinformatics analysis, then verified through biotinylated RNA pull-down and dual-luciferase reporter assays. The mechanism, circ-0003006, probably acted as a sponge of miR‑542‑3p and regulated HIF-1A levels in hepatocellular carcinoma cells. Moreover, HIF-1A overexpression abolished the effect of circ-0003006 inhibition on the progression of hepatocellular carcinoma cells. The subcutaneous tumor formation experiment indicated that circ-0003006 knockdown inhibited the HCC cell growth in vivo.

Conclusion: Circ-0003006 was demonstrated to promote HCC progression in vitro and in vivo by sponging miR‑542‑3p to release the inhibition on HIF-1A.

Citing Articles

Emerging roles of CircRNA-miRNA networks in cancer development and therapeutic response.

Hashemi M, Khosroshahi E, Daneii P, Hassanpoor A, Eslami M, Koohpar Z Noncoding RNA Res. 2024; 10:98-115.

PMID: 39351450 PMC: 11440256. DOI: 10.1016/j.ncrna.2024.09.006.


Emerging role of circRNAs in cancer under hypoxia.

Lai Q, Li W, Wang H, Xu S, Deng Z Oncol Lett. 2022; 24(4):372.

PMID: 36238836 PMC: 9494632. DOI: 10.3892/ol.2022.13492.


Circular RNAs modulate Hippo-YAP signaling: functional mechanisms in cancer.

Qadir J, Li F, Yang B Theranostics. 2022; 12(9):4269-4287.

PMID: 35673576 PMC: 9169354. DOI: 10.7150/thno.71708.

References
1.
Bu N, Dong Z, Zhang L, Zhu W, Wei F, Zheng S . CircPVT1 Regulates Cell Proliferation, Apoptosis and Glycolysis in Hepatocellular Carcinoma via miR-377/TRIM23 Axis. Cancer Manag Res. 2020; 12:12945-12956. PMC: 7751302. DOI: 10.2147/CMAR.S280478. View

2.
Zhou Y, Huang Y, Hu K, Zhang Z, Yang J, Wang Z . HIF1A activates the transcription of lncRNA RAET1K to modulate hypoxia-induced glycolysis in hepatocellular carcinoma cells via miR-100-5p. Cell Death Dis. 2020; 11(3):176. PMC: 7062743. DOI: 10.1038/s41419-020-2366-7. View

3.
Ashwal-Fluss R, Meyer M, Pamudurti N, Ivanov A, Bartok O, Hanan M . circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014; 56(1):55-66. DOI: 10.1016/j.molcel.2014.08.019. View

4.
Luo Z, Lu L, Tang Q, Wei W, Chen P, Chen Y . CircCAMSAP1 promotes hepatocellular carcinoma progression through miR-1294/GRAMD1A pathway. J Cell Mol Med. 2021; 25(8):3793-3802. PMC: 8051675. DOI: 10.1111/jcmm.16254. View

5.
Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J . Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015; 25(8):981-4. PMC: 4528056. DOI: 10.1038/cr.2015.82. View